Hyperphosphataemia—a silent killer of patients with renal failure?

Authors:
  • KAKerstin Amann
    Kerstin Amann
  • MGMarie-Luise Gross
    Marie-Luise Gross
  • GLGérard M. London
    Gérard M. London
  • EREberhard Ritz
    Eberhard Ritz

Abstract
For decades, it has been known that patients with end-stage renal failure have an excessive coronary and cardiac risk. There is also widespread consensus that coronary atherosclerosis and its complications are not fully explained by classical risk factors, e.g. dyslipidaemia, elevated homocysteine concentrations, hypertension, insulin resistance, high fibrinogen etc.

This publication has 17 references indexed in Scilit: